AAAAAA

   
Results: 1-9 |
Results: 9
Synthesis of N-arylated oxazolidinones via a palladium catalyzed cross coupling reaction. Application to the synthesis of the antibacterial agent Dup-721
Authors: Madar, DJ Kopecka, H Pireh, D Pease, J Pliushchev, M Sciotti, RJ Wiedeman, PE Djuric, SW
Citation: Dj. Madar et al., Synthesis of N-arylated oxazolidinones via a palladium catalyzed cross coupling reaction. Application to the synthesis of the antibacterial agent Dup-721, TETRAHEDR L, 42(22), 2001, pp. 3681-3684
Structure-activity relationship studies on 1-[2-(4-phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase
Authors: Penning, TD Chandrakumar, NS Chen, BB Chen, HY Desai, BN Djuric, SW Docter, SH Gasiecki, AF Haack, RA Miyashiro, JM Russell, MA Yu, SS Corley, DG Durley, RC Kilpatrick, BF Parnas, BL Askonas, LJ Gierse, JK Harding, EI Highkin, MK Kachur, JF Kim, SH Krivi, GG Villani-Price, D Pyla, EY Smith, WG Ghoreishi-Haack, NS
Citation: Td. Penning et al., Structure-activity relationship studies on 1-[2-(4-phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase, J MED CHEM, 43(4), 2000, pp. 721-735
3,5-bis(trifluoromethyl)pyrazoles: A novel class of NFAT transcription factor regulator
Authors: Djuric, SW BaMaung, NY Basha, A Liu, HQ Luly, JR Madar, DJ Sciotti, RJ Tu, NP Wagenaar, FL Wiedeman, PE Zhou, X Ballaron, S Bauch, J Chen, YW Chiou, XG Fey, T Gauvin, D Gubbins, E Hsieh, GC Marsh, KC Mollison, KW Pong, M Shaughnessy, TK Sheets, MP Smith, M Trevillyan, JM Warrior, U Wegner, CD Carter, GW
Citation: Sw. Djuric et al., 3,5-bis(trifluoromethyl)pyrazoles: A novel class of NFAT transcription factor regulator, J MED CHEM, 43(16), 2000, pp. 2975-2981
Anti-inflammatory & antiallergy agents - Preface
Authors: Djuric, SW
Citation: Sw. Djuric, Anti-inflammatory & antiallergy agents - Preface, CUR PHARM D, 5(10), 1999, pp. NIL_2-NIL_2
Development of a p38 kinase binding assay for high throughput screening
Authors: Warrior, U Chiou, XG Sheets, MP Sciotti, RJ Parry, JM Simmer, RL Surber, BW Burns, DJ Beutel, BA Mollison, KW Djuric, SW Trevillyan, JM
Citation: U. Warrior et al., Development of a p38 kinase binding assay for high throughput screening, J BIOMOL SC, 4(3), 1999, pp. 129-135
Benzofuran based PDE4 inhibitors
Authors: McGarry, DG Regan, JR Volz, FA Hulme, C Moriarty, KJ Djuric, SW Souness, JE Miller, BE Travis, JJ Sweeney, DM
Citation: Dg. Mcgarry et al., Benzofuran based PDE4 inhibitors, BIO MED CH, 7(6), 1999, pp. 1131-1139
Novel cytokine release inhibitors. Part IV: Analogs of podocarpic acid
Authors: He, W Gavai, A Huang, FC Regan, J Hanney, B Poli, G Bruno, J Chan, WK Djuric, SW Yu, KT Zilberstein, A
Citation: W. He et al., Novel cytokine release inhibitors. Part IV: Analogs of podocarpic acid, BIOORG MED, 9(3), 1999, pp. 469-474
Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an(arylsulfonyl)hydroxamic acid template
Authors: Groneberg, RD Burns, CJ Morrissette, MM Ullrich, JW Morris, RL Darnbrough, S Djuric, SW Condon, SM McGeehan, GM Labaudiniere, R Neuenschwander, K Scotese, AC Kline, JA
Citation: Rd. Groneberg et al., Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an(arylsulfonyl)hydroxamic acid template, J MED CHEM, 42(4), 1999, pp. 541-544
Inhibition of p56(lck) tyrosine kinase by isothiazolones
Authors: Trevillyan, JM Chiou, XG Ballaron, SJ Tang, QM Buko, A Sheets, MP Smith, ML Putman, CB Wiedeman, P Tu, N Madar, D Smith, HT Gubbins, EJ Warrior, UP Chen, YW Mollison, KW Faltynek, CR Djuric, SW
Citation: Jm. Trevillyan et al., Inhibition of p56(lck) tyrosine kinase by isothiazolones, ARCH BIOCH, 364(1), 1999, pp. 19-29
Risultati: 1-9 |